National Cancer Institute; Call for Nominations for the National Cancer Institute Director's Consumer Liaison Group, 4521 [07-400]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 20 / Wednesday, January 31, 2007 / Notices
are to respond, including the use of
appropriate automated electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the Office of
Management and Budget, Office of
Regulatory Affairs, New Executive
Office Building, Room 10235,
Washington, DC 20503, Attention: Desk
Officer for NIH. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact: Dr.
Nancy Breen, Ph.D., Project Officer,
Applied Research Program, Division of
Cancer Control and Population Sciences
NCI, NIH, EPN 4005, 6130 Executive
Boulevard MSC 7344. Bethesda,
Maryland 20852–7344, or call the nontoll-free number 301–696–8500 or Email your request, including your
address to breenn@mail.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
Dated: January 23, 2007.
Rachelle Ragland-Greene,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 07–406 Filed 1–30–07; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on PROD1PC62 with NOTICES
National Cancer Institute; Call for
Nominations for the National Cancer
Institute Director’s Consumer Liaison
Group
The National Cancer Institute (NCI)
the Federal Government’s primary
agency for cancer research, is seeking
nominations for four (4) new members
of the NCI Director’s Consumer Liaison
Group (DCLG) which will be appointed
in July, 2007. The DCLG helps NCI to
identify appropriate advocates to serve
on its program and policy advisory
committees.
The National Cancer Institute (NCI)
formed the NCI Director’s Consumer
Liaison Group (DCLG) in 1998 to advise
and make recommendations to the NCI
Director, from the perspective and
viewpoint of cancer consumer
advocates, on a wide variety of issues,
programs, and research priorities. The
VerDate Aug<31>2005
15:08 Jan 30, 2007
Jkt 211001
DCLG gives cancer advocates a channel
to voice their views and concerns. The
DCLG is a 16-member chartered federal
advisory committee that works with NCI
to ensure that those who experience the
burden of cancer also help to shape the
course of the NCI’s research to eradicate
it. Specifically the DCLG members:
• Help develop and establish
processes, mechanisms and criteria for
identifying appropriate consumer
advocates to serve on a variety of
program and policy advisory
committees responsible for advancing
the mission of the NCI.
• Serve as a primary forum for
discussion issues and concerns and
exchanging viewpoints that are
important to the broad development of
the NCI programming and research
priorities.
• Establish and maintain strong
collaborations between the NCI and the
cancer advocacy community to reach
common goals.
Eligibility Requirements: NCI looks for
strong, highly qualified candidates who
fulfill the following eligibility criteria:
• Demonstrate involvement in the
cancer experience as a cancer survivor,
a caregiver to someone who has cancer,
or as a professional or volunteer who
works with cancer survivors, patients,
or caregivers;
• Have a constituency with which
she/he regularly communicates on
cancer issues and with which she/he is
able to serve as a conduit for
information, both to and from NCI.
Nominees who meet the minimum
eligibility requirements will be
evaluated further based on the following
qualities:
• Cancer advocacy experience; ability
to represent all cancer survivors;
• Possession of strong leadership,
communication, and collaboration
skills;
• Ability to advise on broad cross
cutting cancer issues;
• Ability to facilitate dialogue
between NCI and the cancer advocacy
community.
DCLG members must be committed to
participating in all activities of the
DCLG which includes at least two
meetings a year in Bethesda, MD.
Characteristics of the DCLG. In
addition to the criteria for individual
candidates, the following characteristics
of the DCLG as a group are balanced to
ensure that it reflects the breadth and
diversity of the consumer advocacy
community:
• Racial and ethnic balance
• A broad mix of cancer sites
• Expertise with advocacy
organizations (local, regional, or
national)
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
4521
• Geographical diversity
• Gender
• Age diversity
Selection Process. A call for
nominations is disseminated annually
to a broad range of groups, including
local, regional and national
organizations, to encourage nominations
of candidates reflecting the diversity
sought for the DCLG. Individuals may
nominate themselves. All nominees are
screened for eligibility, and then
evaluated according to the criteria. A
list of highly qualified candidates who
reflect balance and diversity of
representation is forwarded to the
Director, NCI who selects the DCLG
members. The original members of the
DCLG endorsed this process and the
criteria developed to evaluate the
applications of potential DCLG
members, and this process is used to
select future members.
To receive a nomination package for
the DCLG, send your name, advocacy/
voluntary organization affiliation (if
any), address, phone number and E-mail
information to: Palladian Partners, Inc.,
Attn: DCLG 2007 Selection Process,
1010 Wayne Avenue, Suite 1200, Silver
Spring, MD 20910, Phone: (301) 650–
8660, Fax: (301) 650–8676.
Nominations must be postmarked by
March 30, 2007.
Dated: January 23, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy, National Institutes of
Health.
[FR Doc. 07–400 Filed 1–30–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel,
February 27, 2007, 12 p.m. to February
27, 2007, 4 p.m., National Institutes of
Health, 6130 Executive Blvd., Rockville,
MD 20852 which was published in the
Federal Register on December 28, 2006,
71 FR 78214.
The meeting notice is changed to
reflect the change in the name of the
committee from ‘‘SBIR Topic 230
(Phases I & II)’’ to ‘‘SBIR, Synthesis
Stable Isotope-Labeled Steroids as
Internal Standards.’’ The meeting is
closed to the public.
E:\FR\FM\31JAN1.SGM
31JAN1
]]>Agencies
[Federal Register Volume 72, Number 20 (Wednesday, January 31, 2007)]
[Notices]
[Page 4521]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-400]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Call for Nominations for the National
Cancer Institute Director's Consumer Liaison Group
The National Cancer Institute (NCI) the Federal Government's
primary agency for cancer research, is seeking nominations for four (4)
new members of the NCI Director's Consumer Liaison Group (DCLG) which
will be appointed in July, 2007. The DCLG helps NCI to identify
appropriate advocates to serve on its program and policy advisory
committees.
The National Cancer Institute (NCI) formed the NCI Director's
Consumer Liaison Group (DCLG) in 1998 to advise and make
recommendations to the NCI Director, from the perspective and viewpoint
of cancer consumer advocates, on a wide variety of issues, programs,
and research priorities. The DCLG gives cancer advocates a channel to
voice their views and concerns. The DCLG is a 16-member chartered
federal advisory committee that works with NCI to ensure that those who
experience the burden of cancer also help to shape the course of the
NCI's research to eradicate it. Specifically the DCLG members:
Help develop and establish processes, mechanisms and
criteria for identifying appropriate consumer advocates to serve on a
variety of program and policy advisory committees responsible for
advancing the mission of the NCI.
Serve as a primary forum for discussion issues and
concerns and exchanging viewpoints that are important to the broad
development of the NCI programming and research priorities.
Establish and maintain strong collaborations between the
NCI and the cancer advocacy community to reach common goals.
Eligibility Requirements: NCI looks for strong, highly qualified
candidates who fulfill the following eligibility criteria:
Demonstrate involvement in the cancer experience as a
cancer survivor, a caregiver to someone who has cancer, or as a
professional or volunteer who works with cancer survivors, patients, or
caregivers;
Have a constituency with which she/he regularly
communicates on cancer issues and with which she/he is able to serve as
a conduit for information, both to and from NCI.
Nominees who meet the minimum eligibility requirements will be
evaluated further based on the following qualities:
Cancer advocacy experience; ability to represent all
cancer survivors;
Possession of strong leadership, communication, and
collaboration skills;
Ability to advise on broad cross cutting cancer issues;
Ability to facilitate dialogue between NCI and the cancer
advocacy community.
DCLG members must be committed to participating in all activities
of the DCLG which includes at least two meetings a year in Bethesda,
MD.
Characteristics of the DCLG. In addition to the criteria for
individual candidates, the following characteristics of the DCLG as a
group are balanced to ensure that it reflects the breadth and diversity
of the consumer advocacy community:
Racial and ethnic balance
A broad mix of cancer sites
Expertise with advocacy organizations (local, regional, or
national)
Geographical diversity
Gender
Age diversity
Selection Process. A call for nominations is disseminated annually
to a broad range of groups, including local, regional and national
organizations, to encourage nominations of candidates reflecting the
diversity sought for the DCLG. Individuals may nominate themselves. All
nominees are screened for eligibility, and then evaluated according to
the criteria. A list of highly qualified candidates who reflect balance
and diversity of representation is forwarded to the Director, NCI who
selects the DCLG members. The original members of the DCLG endorsed
this process and the criteria developed to evaluate the applications of
potential DCLG members, and this process is used to select future
members.
To receive a nomination package for the DCLG, send your name,
advocacy/voluntary organization affiliation (if any), address, phone
number and E-mail information to: Palladian Partners, Inc., Attn: DCLG
2007 Selection Process, 1010 Wayne Avenue, Suite 1200, Silver Spring,
MD 20910, Phone: (301) 650-8660, Fax: (301) 650-8676.
Nominations must be postmarked by March 30, 2007.
Dated: January 23, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy, National
Institutes of Health.
[FR Doc. 07-400 Filed 1-30-07; 8:45 am]
BILLING CODE 4140-01-M
